Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-571P is a pseudogene annotated as "RNA, U6 small nuclear 571, pseudogene." It is derived from the gene encoding U6 small nuclear RNA (snRNA), a core component of the spliceosomal machinery essential for pre-mRNA splicing in eukaryotes. However, as a pseudogene, RNU6-571P does not encode a functional RNA product and is considered non-coding, lacking known biological or clinical function. Like other U6-related pseudogenes, it is present in the genome as a non-functional copy, often reflecting the evolutionary importance of the U6 snRNA gene but without contributing to splicing or any cellular process. Pseudogenes may occasionally serve as sources for non-coding RNAs with regulatory roles, but there are no reports of RNU6-571P being transcribed into a functional product or involved in disease or drug response. Its expression has been detected in various tissues, but this does not imply function. The functional U6 snRNA is highly conserved and essential for the splicing of pre-mRNA, acting as a catalytic component of the spliceosome. U6 pseudogenes, such as RNU6-571P, are non-functional and prevalent in vertebrate genomes, likely due to the essential nature of the original U6 gene. There are no known therapeutic, diagnostic, or pathological implications linked to RNU6-571P. RNU6-571P is a small nuclear RNA pseudogene with no known function or clinical importance, and it is not considered a molecular target for drugs or therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 571, pseudogene (RNU6-571P).